You are here

Home » Content

Periton Diyaliz Hastalarında Kemik Mineral Dansitometresi ile Damar Kireçlenmesi (Vasküler Kalsifi kasyon) Arasındaki İlişki

The Relationship Between Bone Mineral Densitometry and Vascular Calcifi cation in Peritoneal Dialysis Patients

Journal Name:

  • Türk Nefroloji, Diyaliz ve Transplantasyon Dergisi

Publication Year:

  • 2012
DOI: 
DOI 10.5262/tndt.2012.1003.07

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
OBJECTIVE: Vascular calcifi cation (VC) and disturbed bone mineral metabolism (BMM) are commonly seen in patients with end-stage renal disease (ESRD). Fetuin-A has been found to be signifi cantly low in ESRD patients. The aim of our study was to investigate the relation between coronary artery calcifi cation, BMM and fetuin-A in peritoneal dialysis (PD) patients. MATERIAL and METHODS: 46 PD (M/F=28/18) patients were included in the study. Coronary artery calcifi cation scoring (CACS) was performed by multi slice computed tomography. The patients were divided into 4 groups according to their CACS values as Group 1 (CACS: 0), Group 2 (CACS:1- 99), Group 3 (CACS:100-399) and Group 4 (CACS: ≥400). Serum levels of fetuin-A were measured. Bone mineral densitometry was measured by dual energy X-ray absorptiometer (DEXA). RESULTS: There was a statistically signifi cant difference difference between CACS and femur T scores in PD patients. Femur T scores were found to be decreased while CACS values are increased. We could not fi nd any differences in terms of CACS when we separated patients according to T scores greater or lower than -2. Osteopenic patients were found to be older and they also had low fetuin-A levels. CONCLUSION: We found an important relationship between CACS and bone mineralization in PD patients.
Bookmark/Search this post with
Abstract (Original Language): 
AMAÇ: Son dönem böbrek yetersizliği (SDBY) gelişen hastalarda damar kireçlenmesi (DK) ve kemik mineral metabolizma (KMM) bozukluğu yaygın olarak gözlenmektedir. SDBY hastalarında fetuin-A düzeyinin ileri derecede düşük olduğu saptanmıştır. Çalışmamızın amacı periton diyaliz (PD) hastalarında koroner arter kireçlenmesi (KAKS), KMM ve fetuin-A arasındaki ilişkiyi incelemektir. GEREÇ ve YÖNTEMLER: Çalışmamıza 46 PD (E/K=28/18) hastası alınmıştır. Hastalara çok kesitli bilgisayarlı tomografi ile koroner arter kalsiyum skorlaması (KAKS) yapıldı. KAKS değerlerine göre hastalar Grup 1 (KAKS 0), Grup 2 (KAKS: 1-99), Grup 3 (KAKS: 100-399) ve Grup 4 (KAKS: ≥400) olmak üzere 4 gruba ayrıldı. Serumda fetuin-A düzeyi çalışıldı. DEXA ile kemik mineral dansitometresi ölçüldü. BULGULAR: Periton diyaliz hastalarının KAKS ile femur T skorları arasında istatistiksel olarak anlamlı ilişki saptanmıştır. Hastalarının KAKS’ı arttıkça femur T skoru azalmaktaydı. Buna ek olarak T skoru -2’nin altında ve üstünde olan hastalar karşılaştırıldığında KAKS değerleri bakımından anlamlı bir farklılık saptanmamıştır. İstatistiksel açıdan anlamlı olmamakla birlikte osteopenik olan PD hastaları daha yaşlıydı ve bu hastaların fetuin-A değerleri daha düşüktü. SONUÇ: Periton diyaliz hastalarında KAKS ile kemik mineralizasyonu arasındaki anlamlı bir ilişki saptadık.
FULL TEXT (PDF): 
PDF icon arastrmx_172977_21_pp_242-246.pdf
  • 3
242-246
  • Turkish

REFERENCES

References: 

1. Ambrus C, Marton A, Nemeth ZK, Mucsi I: Bone mineral density
in patients on maintenance dialysis. Int Urol Nephrol 2010; 42 (3):
723-739
2. Jadoul M, Albert JM, Akiba T, Akizawa T, Arab L, Bragg-Gresham
JL, Mason N, Prutz KG, Young EW, Pisoni RL: Incidence and risk
factors for hip or other bone fractures among hemodialysis patients
in the Dialysis Outcomes and Practice Patterns Study. Kidney Int
2006; 70 (7): 1358-1366
3. Mittalhenkle A, Gillen DL, Stehman-Breen CO: Increased risk of
mortality associated with hip fracture in the dialysis population. Am
J Kidney Dis 2004; 44 (4): 672-679
4. Ketteler M, Gross ML, Ritz E: Calcifi cation and cardiovascular
problems in renal failure. Kidney Int Suppl 2005 (94): 120-127
5. Matsubara K, Suliman ME, Qureshi AR, Axelsson J, Martola L,
Heimbürger O, Barany P, Stenvinkel P, Lindholm B: Bone mineral
density in end-stage renal disease patients: Association with
wasting, cardiovascular disease and mortality. Blood Purif 2008; 26
(3): 284-290
6. Fontaine MA, Albert A, Dubois B, Saint-Remy A, Rorive G:
Fracture and bone mineral density in hemodialysis patients. Clin
Nephrol 2000; 54 (3): 218-226
7. Spasovski GB: Bone health and vascular calcifi cation relationships
in chronic kidney disease. Int Urol Nephrol 2007; 39 (4): 1209-1216
8. London GM, Marty C, Marchais SJ, Guerin AP, Metivier F, de
Vernejoul MC: Arterial calcifi cations and bone histomorphometry in
end-stage renal disease. J Am Soc Nephrol 2004; 15 (7): 1943-1951
9. Schinke T, Amendt C, Trindl A, Poschke O, Muller-Esterl W,
Jahnen-Dechent W: The serum protein alpha2-HS glycoprotein/
fetuin inhibits apatite formation in vitro and in mineralizing calvaria
cells. A possible role in mineralization and calcium homeostasis. J
Biol Chem 1996; 271 (34): 20789-20796
10. Kirkpantur A, Altun B, Hazirolan T, Akata D, Arici M, Kirazli
S, Turgan C: Association among serum fetuin-A level, coronary
artery calcifi cation and bone mineral densitometry in maintenance
hemodialysis patients. Artif Organs 2009; 33 (10): 844-854
11. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte
M Jr, Detrano R: Quantifi cation of coronary artery calcium using
ultrafast computed tomography. J Am Coll Cardiol 1990; 15 (4):
827-832
12. Proudfoot D, Skepper JN, Shanahan CM, Weissberg PL:
Calcifi cation of human vascular cells in vitro is correlated with
high levels of matrix Gla protein and low levels of osteopontin
expression. Arterioscler Thromb Vasc Biol 1998; 18 (3): 379-388
13. Kramer H, Toto R, Peshock R, Cooper R, Victor R: Association
between chronic kidney disease and coronary artery calcifi cation:
The Dallas Heart Study. J Am Soc Nephrol 2005; 16 (2): 507-513
14. Shaw LJ, Raggi P, Schisterman E, Berman DS, Callister TQ:
Prognostic value of cardiac risk factors and coronary artery calcium
screening for all-cause mortality. Radiology 2003; 228 (3): 826-833
15. Raggi P, Shaw LJ, Berman DS, Callister TQ: Prognostic value of
coronary artery calcium screening in subjects with and without
diabetes. J Am Coll Cardiol 2004; 43 (9): 1663-1669
16. Dellegrottaglie S, Sanz J, Rajagopalan S: Molecular determinants
of vascular calcifi cation: A bench to bedside view. Curr Mol Med
2006; 6 (5): 515-524
17. Chen Q, Kaji H, Iu MF, Nomura R, Sowa H, Yamauchi M, Tsukamoto
T, Sugimoto T, Chihara K: Effects of an excess and a defi ciency
of endogenous parathyroid hormone on volumetric bone mineral
density and bone geometry determined by peripheral quantitative
computed tomography in female subjects. J Clin Endocrinol Metab
2003; 88 (10): 4655-4658
18. Barnas U, Schmidt A, Seidl G, Kaider A, Pietschmann P, Mayer G:
A comparison of quantitative computed tomography and dual X-ray
absorptiometry for evaluation of bone mineral density in patients on
chronic hemodialysis. Am J Kidney Dis 2001; 37 (6): 1247-1252

Thank you for copying data from http://www.arastirmax.com